Simon, Hans-Uwe; Cools, Jan (2007). Novel approaches to therapy of hypereosinophilic syndromes. Immunology and allergy clinics of North America, 27(3), pp. 519-27. Philadelphia, Pa.: Elsevier 10.1016/j.iac.2007.07.003
Full text not available from this repository.There has been recent progress in the understanding of the pathogenesis of the hypereosinophilic syndromes (HES). This led to the distinction of subgroups, in which the underlying cause has been identified. Consequently, new treatment options became available, such as imatinib and mepolizumab, which proved to be promising. This article summarizes these new pharmacologic approaches to the therapy of HES.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology |
UniBE Contributor: |
Simon, Hans-Uwe |
ISSN: |
0889-8561 |
ISBN: |
17868862 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:54 |
Last Modified: |
05 Dec 2022 14:16 |
Publisher DOI: |
10.1016/j.iac.2007.07.003 |
PubMed ID: |
17868862 |
Web of Science ID: |
000250174800012 |
URI: |
https://boris.unibe.ch/id/eprint/23008 (FactScience: 38541) |
Actions (login required)
 |
Edit item |